5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Pre-Eclampsia in 1 studies
5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist
Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viall, CA | 1 |
| Chen, Q | 1 |
| Liu, B | 1 |
| Hickey, A | 1 |
| Snowise, S | 1 |
| Salmon, JE | 1 |
| Stone, PR | 1 |
| Chamley, LW | 1 |
1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Pre-Eclampsia
| Article | Year |
|---|---|
Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris.
Topics: Antibodies, Antiphospholipid; Antibodies, Monoclonal; Apoptosis; beta-Cyclodextrins; Cells, Cultured | 2013 |